Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Antibiotic Essentials
Burke A. Cunha
CHAPTER 1:
Overview of Antimicrobial Therapy
FACTORS IN ANTIBIOTIC SELECTION
FACTORS IN ANTIBIOTIC DOSING
MICROBIOLOGY AND SUSCEPTIBILITY TESTING
PK/PD AND OTHER CONSIDERATIONS IN ANTIMICROBIAL THERAPY
EMPIRIC VS SPECIFIC ANTIBIOTIC THERAPY
ANTIBIOTIC FAILURE
PITFALLS IN ANTIBIOTIC PRESCRIBING
CHAPTER 2:
Empiric Therapy Based on Clinical Syndrome
CHAPTER 3:
Antibiotic Susceptibility Profiles and Initial Therapy of Isolates Pending Susceptibility Results
AEROBIC ISOLATES
CAPNOPHILIC ISOLATES+
ANAEROBIC ISOLATES
YEASTS/FUNGI
CHAPTER 4:
Parasites, Fungi, Unusual Organisms*
CHAPTER 5:
HIV Infection
HIV INFECTION OVERVIEW
STAGES OF HIV INFECTION
ACUTE (PRIMARY) HIV INFECTION
APPROACH TO HIV TESTING (Figure 5.2)
INITIAL ASSESSMENT OF HIV INFECTION
INDICATIONS FOR TREATMENT OF HIV INFECTION
ANTIRETROVIRAL TREATMENT
ANTIRETROVIRAL TREATMENT FAILURE (Table 5.6)
PROPHYLAXIS OF OPPORTUNISTIC INFECTIONS IN HIV (Tables 5.7 and 5.8)
TREATMENT OF OPPORTUNISTIC INFECTIONS IN HIV
Aspergillosis, Invasive Pulmonary
Bacterial Pneumonia
Pneumocystis (carinii) jiroveci Pneumonia (PCP)
Pulmonary Tuberculosis (for isolates sensitive to INH and rifampin)
CMV Retinitis
CMV Encephalitis
CMV Retinitis
CMV Encephalitis
Cryptococcal Meningitis
Progressive Multifocal Encephalopathy (PML)
Toxoplasma Encephalitis
Campylobacter (C. jejuni) Enteritis
Clostridium difficile Diarrhea/Colitis
CMV Esophagitis/Colitis
Cryptosporidia Enteritis
Isospora (Isospora belli) Enteritis
Microsporidia Enteritis
Oropharyngeal/Esophageal Candidiasis
Oral Thrush (Candida)
Candida Esophagitis
Salmonella Gastroenteritis (non-S. typhi)
Shigella (Shigella sp.) Enteritis
TREATMENT OF OTHER OPPORTUNISTIC INFECTIONS IN HIV
Candida Vaginitis
Coccidioidomycosis (C. immitis) Infection
Extrapulmonary Tuberculosis
Herpes Simplex Virus (HSV) Disease
Herpes Simplex (genital/oral)
Herpes Encephalitis (HSV-1)
Histoplasmosis (H. capsulatum), Disseminated
Mycobacterium avium-intracellulare (MAI)
Varicella Zoster Virus (VZV)
HIV COINFECTIONS (HBV/HCV)
Hepatitis B Virus (HBV)
Hepatitis C Virus (HCV)
CHAPTER 6:
Prophylaxis and Immunizations
SURGICAL PROPHYLAXIS
POST-EXPOSURE PROPHYLAXIS
CHRONIC MEDICAL PROPHYLAXIS
EENDOCARDITIS PROPHYLAXIS
TRAVEL PROPHYLAXIS
TETANUS PROPHYLAXIS
IMMUNIZATIONS
CHAPTER 7:
Pediatric Infectious Diseases and Pediatric Drug Summaries
CHAPTER 8:
CHEST X-RAY ATLAS
CHAPTER 9:
Infectious Disease Differential Diagnosis
CHAPTER 10:
Antibiotic Pearls & Pitfall
PENICILLIN
AMPICILLIN
AMOXICILLIN/CLAVULANIC ACID
ORAL ANTI-STAPHYLOCOCCAL PENICILLINS
ORAL ANTI-PSEUDOMONAL PENICILLINS
PARENTERAL FIRST-GENERATION CEPHALOSPORINS
ORAL FIRST-GENERATION CEPHALOSPORINS
PARENTERAL SECOND-GENERATION CEPHALOSPORINS
ORAL SECOND-GENERATION CEPHALOSPORINS
PARENTERAL THIRD-GENERATION CEPHALOSPORINS
ORAL THIRD-GENERATION CEPHALOSPORINS
PARENTERAL FOURTH-GENERATION CEPHALOSPORIN (CEFEPIME)
PARENTERAL ANTI-MRSA CEPHALOSPORIN (CEFTAROLINE)
MONOBACTAMS (AZTHREONAM)
CARBAPENEMS (IMIPENEM, MEROPENEM, ERTAPENEM, DORIPENEM)
BETA-LACTAMASE INHIBITOR COMBINATIONS
TETRACYCLINES (DOXYCYCLINE, MINOCYCLINE)
CHLORAMPHENICOL
CLINDAMYCIN
AMINOGLYCOSIDES (GENTAMICIN, TOBRAMYCIN, AMIKACIN)
TMP–SMX
QUINOLONES (CIPROFLOXACIN, OFLOXACIN, LEVOFLOXACIN, MOXIFLOXACIN)
NITROFURANTOIN
VANCOMYCIN
OXAZOLIDINONES (LINEZOLID, TEDIZOLID)
QUINUPRISTIN/DALFOPRISTIN
LIPOPEPTIDE (DAPTOMYCIN)
TIGECYCLINE
MACROLIDES (ERYTHROMYCIN, AZITHROMYCIN, CLARITHROMYCIN)
METRONIDAZOLE
LIPOGLYCOPEPTIDES (TELEVANCIN, ORITAVANCIN, DALBAVANCIN)
FOSFOMYCIN
COLISTIN AND POLYMYXIN B
NITAZOXANIDE
CHAPTER 11:
Antimicrobial Drug Summaries
APPENDIX
COLOR ATLAS
INDEX
TOC
Index
×
Chapter Notes
Save
Clear
